IGC Pharma (IGS1) Q2 2025 Earnings Report
DE:IGS1 Q2 2025 EPS Results
- Actual EPS
- -EUR 0.02
- Consensus EPS
- -EUR 0.03
- Beat/Miss
- Beat by +EUR 0.01
- One Year Ago EPS
- -EUR 0.04
DE:IGS1 Q2 2025 Revenue Results
- Actual Revenue
- EUR 368.37K
- Expected Revenue
- EUR 260.19K
- Beat/Miss
- Beat by +EUR 108.19K
- YoY Revenue Growth
- +41.58%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 11/14/2024
- Time
- Before Open
- Conference Call
- Thursday, November 14, 2024
DE:IGS1 Upcoming Earnings
IGC Pharma's next earnings date is estimated for November 18, 2026, based on past reporting schedules.
Q2 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:IGS1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 18, 2026 | 2027 (Q2) | -0.02- | -0.02 | ― | ― |
| Jun 15, 2026 | 2026 (Q4) | ―-0.02 | -0.02 | 0.00% (+0.00) | |
| Mar 19, 2026 | 2026 (Q3) | -0.02-0.01 | -0.02 | 50.00% (+0.01) | |
| Nov 17, 2025 | 2026 (Q2) | -0.02-0.02 | -0.02 | 0.00% (+0.00) | |
| Aug 19, 2025 | 2026 (Q1) | ―- | -0.03 | ― | |
| Jun 30, 2025 | 2025 (Q4) | -0.02-0.02 | -0.03 | 33.33% (+0.01) | |
| Feb 18, 2025 | 2025 (Q3) | -0.03-0.02 | -0.08 | 77.78% (+0.06) | |
| Nov 14, 2024 | 2025 (Q2) | -0.03-0.02 | -0.04 | 60.00% (+0.03) | |
| Aug 09, 2024 | 2025 (Q1) | -0.03-0.03 | -0.03 | 23.08% (+0.01) | |
| Jun 24, 2024 | 2024 (Q4) | -0.04-0.03 | -0.07 | 53.95% (+0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
